A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia: Erratum
We have been notified that the article by Dr Gahan Pandina et al titled "A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia," which was published in the June issue of the Journal (J Clin Psychopharmacol. 2010; 30:fc235-244), contains an error in the Abstract.
The Abstract should read:
"The patients received an injection of paliperidone palmitate at 150 mg eq or placebo in the deltoid muscle on day 1 and the assigned fixed dose or placebo in the deltoid or gluteal muscle on day 8 and then once monthly (days 36 and 64). No oral supplementation was used."
© 2010 Lippincott Williams & Wilkins, Inc.
Pandina GJ, Lindenmayer J-P, Lull J, et al. A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia. J Clin Psychopharmacol